Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine
Wednesday, December 11 | Barriers in Translation for Novel Products in Trauma and Critical Care
Discussion and talks will focus upon funding, translation, cell product production and processing
2019-12-11 11:00:00 - 2019-12-11 17:00:00
Registration Open – Aragon Ballroom Foyer
Badge and Materials Pickup
2019-12-11 14:30:00 - 2019-12-11 14:35:00
Welcome & Introductions
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
2019-12-11 14:35:00 - 2019-12-11 15:20:00
Session 1 | Sustainability of Research and Successful Translation of Novel Therapeutics in Trauma and Critical Care: from Bench to Bedside and Beyond
Discussion will focus upon funding support for the translational pipeline which includes the infrastructure needed for pre-clinical and clinical trials in trauma and critical care. Funding from federal sources, industry, philanthropy and venture capital will be discussed. Panelists will include representation from the NIH, BARDA, DOD, industry stakeholders and a venture capital firm.
Moderator(s)- Raymond Goodrich PhD
Executive Director, Infectious Disease Research Center
Office of the Vice President for Research
Professor, Department of Microbiology, Immunology and Pathology,
Colorado State University
Panelists- Geoffrey Ling MD, PhD
COL, USA, Ret.
Chief Executive Officer at SunQ, LLC
Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office - Keith Hoots MD
Director, Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute - Ken Kleinhenz
VP of Regulatory for Cellular Therapies
CSSi LifeSciences - Mary Homer PhD
Chief United States Radiological and Nuclear Countermeasures, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA) - Terry Opgenorth PhD
Vice President & Director of Launchpad
Colorado State University Ventures - Wilbur Malloy MA, MLS(ASCP)SBB
Lieutenant Colonel, US Army (Retired)
Health Science Program Manager
Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC)
2019-12-11 15:20:00 - 2019-12-11 17:00:00
Session 2 | Challenges in Product Development, Cell Production and Processing
Discussion will focus upon the translational barriers and challenges that exist in cell product production, development and processing. Panelists will include representation from the private industry, blood banks, NIH and academic centers involved in this space.
Moderator(s)- David McKenna MD
Professor of Transfusion Medicine
Director of the Division of Transfusion Medicine
University of Minnesota
2019-12-11 15:21:00 - 2019-12-11 15:40:00
Analysis of Stem Cell Heterogeneity to Identify Potency Markers
- Dave Stroncek MD
Director for Center for Cellular Engineering, NIH Clinical Center
2019-12-11 15:40:00 - 2019-12-11 16:00:00
Challenges of Clinical Cell Product Production in an Academic Center: Manufacturing Autologous Regulatory T Cell Products
- Jonathan Esensten MD, PhD
Medical Director, UCSF HICTF and GMP Facility
Medical Director, Zuckerberg San Francisco General Hospital Blood Bank and Transfusion Service
Assistant Adjunct Professor, UCSF, Dept. of Laboratory Medicine
2019-12-11 16:00:00 - 2019-12-11 17:00:00
Panel Discussion on Product Development, Processing and Production
Moderator(s)- Kenneth Bertram MD, PhD
Co-Chair CTTACC
COL, USA, Ret.
Professor of Regenerative Medicine
Wake Forest University
Panelists- Becky Cap
Sr. Vice President, Chief Operating Officer, GenCure - Fabio Triolo D.d.R., M.Phil., PhD
Associate Professor of Clinical and Translational Sciences
Director, Cellular Therapy Core
Department of Pediatric Surgery
McGovern Medical School at UTHealth - Jon Rowley PhD
Chief Executive & Technology Officer, RoosterBio, Inc. - Julie Allickson PhD
Director, Regenerative Medicine Clinical Center
Wake Forest Institute for Regenerative Medicine - Priya Baraniak PhD
Vice President, Corporate Development
OrganaBio, LLC - Robert Mays PhD
Vice President, Regenerative Medicine
Head of Neurosciences, Athersys, Inc.
2019-12-11 17:00:00 - 2019-12-11 17:50:00
Session 3 | Optimizing Cell Product Development and Delivery to Patients
Discussion will focus upon the current successes and challenges that exist in finalizing the end of product development which includes optimal cryopreservation, storage, shipping, handling and delivery of the final product to patients. These are areas that are critical for the success and safety of the products, clinical trials and final patient outcomes. Panelists will include representation from the private industry, blood banks and academic centers involved in this space.
Moderator(s)- Aby J. Mathew PhD
Senior VP & CTO
BioLife Solutions - Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Panelists- Bob Harman DVM, MPVM
Chief Scientific Officer & Co-Founder of Personalized Stem Cells, Inc. - Charles Cox MD
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth - Christopher Murphy
M SGT, USA, Ret.
President Combat Medical - David McKenna MD
Professor of Transfusion Medicine
Director of the Division of Transfusion Medicine
University of Minnesota - Donna Chang
President & CEO
Hope Biosciences - Fabio Triolo D.d.R., M.Phil., PhD
Associate Professor of Clinical and Translational Sciences
Director, Cellular Therapy Core
Department of Pediatric Surgery
McGovern Medical School at UTHealth
2019-12-11 18:00:00 - 2019-12-11 18:50:00
Reception – Buena Vista Terrace
2019-12-11 18:50:00 - 2019-12-11 19:00:00
Introduction of Keynote Speaker – Santiago Courtyard
- Martin Schreiber MD
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
2019-12-11 19:00:00 - 2019-12-11 19:30:00
2019 Keynote | The Power of Yes
- Geoffrey Ling MD, PhD
COL, USA, Ret.
Chief Executive Officer at SunQ, LLC
Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office
2019-12-11 19:30:00 - 2019-12-11 21:00:00
Dinner – Santiago Courtyard
Thursday, December 12 | Transfusion Medicine in Trauma and Critical Care
The goal of this session is to discuss and understand pertinent issues in transfusion medicine and novel blood products related to the bleeding and acutely injured trauma patient. Topics of discussion will focus around novel blood products and adjuncts to resuscitation in bleeding patients.
2019-12-12 07:00:00 - 2019-12-12 08:00:00
Breakfast | Aragon Lawn
2019-12-12 07:00:00 - 2019-12-12 17:00:00
Registration Area Open – Aragon Ballroom Foyer
Badge and Materials Pickup
2019-12-12 08:00:00 - 2019-12-12 08:05:00
Welcome & Introduction
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Session 1 | Whole Blood – The First Cell Therapy in Trauma
Moderator(s)- Paul Ness MD
Senior Director, Division of Transfusion Medicine
Professor of Pathology
Johns Hopkins University - Philip Spinella MD, FCCM
Professor of Pediatrics
Washington Univ School of Medicine St. Louis
2019-12-12 08:05:00 - 2019-12-12 08:20:00
Civilian Whole Blood Use: The Portland, OR Experience
- Martin Schreiber MD
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
2019-12-12 08:20:00 - 2019-12-12 08:35:00
Military Whole Blood Use
- Stacy Shackleford MD
Col, USAF MC
Joint Trauma System, Chief
DHA Combat Support
2019-12-12 08:35:00 - 2019-12-12 08:50:00
Civilian Whole Blood Use: The Pittsburgh, PA Experience
- Jason Sperry MD, MPH
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh
2019-12-12 08:50:00 - 2019-12-12 09:05:00
Southwest Texas Regional Advisory Council for Trauma Pre-hospital Whole Blood Resuscitation Program
- Donald Jenkins MD
COL, USAF, Ret.
Professor of Surgery Uniformed Services University
Professor/Clinical, Division of Trauma and Emergency Surgery
Vice Chair for Quality, Department of Surgery UT San Antonio
Betty and Bob Kelso Distinguished Chair in Burn and Trauma Surgery
2019-12-12 09:05:00 - 2019-12-12 09:20:00
Question & Answer Panel | Session 1
–
2019-12-12 09:20:00 - 2019-12-12 09:40:00
Coffee Break – Aragon Ballroom Foyer
Visit Exhibits
Session 2 | Novel Resuscitation Adjuncts and Blood Products in Trauma
Moderator(s)- Matthew Neal MD
Roberta G. Simmons Assistant Professor of Surgery
Assistant Professor of Clinical and Translational Science and Critical Care Medicine
University of Pittsburgh - Victor Macdonald PhD
SME Blood Products
USAMRMC
2019-12-12 09:40:00 - 2019-12-12 09:55:00
Resuscitation Adjuncts in Trauma
- Hasan Alam MD
Norman W. Thompson Professor of Surgery
Section Head of General Surgery
University of Michigan
2019-12-12 09:55:00 - 2019-12-12 10:10:00
COMBAT vs. PAMPER Prehospital Plasma First Resuscitation : Impact of Transport Time
- Ernest Moore MD
Professor of Surgery
Vice Chair of Research
Editor of Journal of Trauma and Acute Care Surgery
2019-12-12 10:10:00 - 2019-12-12 10:25:00
Tranxanemic Acid as a Resuscitative Adjunct for Treatment of TBI
- Martin Schreiber MD
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
2019-12-12 10:25:00 - 2019-12-12 10:40:00
Endothelial and Mitochondrial Effects of TXA
- Joseph Rappold MD
Co-Chair CTTACC
CAPT, USN, Ret.
Professor of Surgery
Maine Medical Center Tufts University
2019-12-12 10:40:00 - 2019-12-12 10:55:00
Precision Approaches to Trauma Resuscitation – The TACTIC Trial
- Karim Brohi MD
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
2019-12-12 10:55:00 - 2019-12-12 11:10:00
Field of Wrecked Dreams: Tale of a Sole Survivor: HBOCs Beyond the Hype and Rhetoric of the Past
- Zafiris Zafirelis
Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
2019-12-12 11:10:00 - 2019-12-12 11:25:00
Question & Answer Panel | Session 2
2019-12-12 11:25:00 - 2019-12-12 12:15:00
Discussion Panel on Challenges in the Development, Study and Implementation of Pre-hospital Interventions
Moderator(s)- Joseph Rappold MD
Co-Chair CTTACC
CAPT, USN, Ret.
Professor of Surgery
Maine Medical Center Tufts University - Martin Schreiber MD
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
Panelists- Andrew (Andre) Cap MD, PhD
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research - Beth Shaz MD
President AABB
Chief Medical and Scientific Officer
Senior Vice President at New York Blood Center - Christophe Martinaud MD
Professor of Transfusion Medicine and Cell Therapy
French Military Blood Institute Clamart - Ernest Moore MD
Professor of Surgery
Vice Chair of Research
Editor of Journal of Trauma and Acute Care Surgery - Jason Sperry MD, MPH
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh - Karim Brohi MD
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
2019-12-12 12:15:00 - 2019-12-12 13:15:00
Lunch – Aragon Lawn
Visit Exhibits
Session 3 | Dried Plasma, Artificial RBCs and Pathogen Reduction of Blood
Moderator(s)- Jeffrey McCullough MD
Emeritus Professor,
University of Minnesota - Richard Weiskopf MD
Professor Emeritus
University of California, San Francisco
2019-12-12 13:15:00 - 2019-12-12 13:30:00
Alternative uses for Pathogen-Reduced Plasma: It’s not all about the clot
- Rosemary Kozar MD, PhD
Professor of Surgery
Director of Translational Research Shock Trauma
University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center
2019-12-12 13:30:00 - 2019-12-12 13:45:00
Pathogen Reduction in Transfusion Safety of Novel Blood Products
- Larry Corash MD
Senior VP and Chief Scientific Officer Cerus Inc.
2019-12-12 13:45:00 - 2019-12-12 14:00:00
Encapsulated HBOCs to Artificial & Engineered Red Cells: Update and Preclinical Results
- Allan Doctor MD
Professor of Pediatrics, Biochemistry and Bioengineering
Director, Center for Blood Oxygen Transport and Hemostasis
University of Maryland School of Medicine
2019-12-12 14:00:00 - 2019-12-12 14:15:00
Blood Banks Providing Novel and Alternative Blood Products
- Beth Shaz MD
President AABB
Chief Medical and Scientific Officer
Senior Vice President at New York Blood Center
2019-12-12 14:15:00 - 2019-12-12 14:30:00
Question & Answer Panel | Session 3
2019-12-12 14:30:00 - 2019-12-12 14:50:00
Coffee Break – Aragon Ballroom Foyer
Visit Exhibits
Session 4 | Novel Platelet and Platelet Derived Products
Moderator(s)- Heather Pidcoke MD, PhD
Chief Medical Research Officer
Associate Director, Research
Translational Medicine Institute
Colorado State University - Lucy Kornblith MD
Assistant Professor of Surgery
Trauma Surgery and Surgical Critical Care
University of California San Francisco
Zuckerberg San Francisco General Hospital
2019-12-12 14:50:00 - 2019-12-12 15:05:00
Freeze Dried Platelets in Trauma Related Applications- Pre-clinical to Clinical Translation
- Mike Fitzpatrick PhD
COL, USA, Ret.
President & Director of Research and Development, Cellphire Inc.
2019-12-12 15:05:00 - 2019-12-12 15:20:00
Platelets and Platelet Dysfunction in Trauma
- Karim Brohi MD
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
2019-12-12 15:20:00 - 2019-12-12 15:35:00
Cold Stored Platelets in Trauma – The Optimal Product for Military and Civilian Use
- Andrew (Andre) Cap MD, PhD
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research
2019-12-12 15:35:00 - 2019-12-12 15:50:00
Platelet Biology and Cytoskeletal Mechanics
- Owen McCarty PhD
Professor and Chair of Department of Biomedical Engineering
Professor of Department of Cell & Development Biology
Oregon Health & Science University
2019-12-12 15:50:00 - 2019-12-12 16:05:00
Regulation of Vascular Stability by 4C Platelets: defining new measures of platelet function?
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
2019-12-12 16:05:00 - 2019-12-12 16:20:00
Freeze Dried Platelets in Treating Traumatic Brain Injury
- Alpa Mahuvakar Trivedi PhD
Research Professor
Department of Laboratory Medicine, UCSF
2019-12-12 16:20:00 - 2019-12-12 16:35:00
Cold Stored Platelets: The Rationale for a Clinical Trial of 4C vs 22C Platelets in Bleeding Patients
- Philip Spinella MD, FCCM
Professor of Pediatrics
Washington Univ School of Medicine St. Louis
2019-12-12 16:35:00 - 2019-12-12 16:50:00
Question & Answer Panel | Session 4
Session 5 | Product Development, Support and Regulatory Approval of Novel Blood Products
2019-12-12 16:50:00 - 2019-12-12 17:45:00
Discussion Panel: Novel Blood Product Development in Transfusion Medicine
Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products. Including dried plasma, dried platelets, dried cryoprecipitate, and more.
Moderator(s)- Kenneth Bertram MD, PhD
Co-Chair CTTACC
COL, USA, Ret.
Professor of Regenerative Medicine
Wake Forest University - Richard Gonzales MS, MT(ASCP)SBB
COL, USA, Ret.
President and CEO
Richblo2d Biologics Consulting Services LLC
Panelists- Andrew (Andre) Cap MD, PhD
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research - Larry Corash MD
Senior VP and Chief Scientific Officer Cerus Inc. - Mark Popovsky MD
Chief Medical Officer
Velico Medical, Inc - Mike Fitzpatrick PhD
COL, USA, Ret.
President & Director of Research and Development, Cellphire Inc. - Peter Marks MD, PhD
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration - Wilbur Malloy MA, MLS(ASCP)SBB
Lieutenant Colonel, US Army (Retired)
Health Science Program Manager
Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC) - Zafiris Zafirelis
Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
2019-12-12 18:00:00 - 2019-12-12 19:00:00
Reception – Aragon Terrace
2019-12-12 19:00:00 - 2019-12-12 21:00:00
Dinner – Aragon Lawn
Friday, December 13 | Cellular Therapies in Trauma and Critical Care Medicine
The goal of this session is to discuss and learn about the state of the science of cellular therapies in trauma and critical care. Pre-clinical and clinical studies will be presented in traumatic brain injury (TBI), Spinal Cord Injury (SCI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), cardiac disease, wound healing and tissue and bone regeneration.
2019-12-13 07:00:00 - 2019-12-13 08:00:00
Breakfast – Aragon Lawn
2019-12-13 07:00:00 - 2019-12-13 13:00:00
Registration Area Open – Aragon Ballroom Foyer
Badge and Materials Pickup
Session 1 | Cellular Therapies in Critical Care Medicine
Moderator(s)- Charles Cox MD
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth - Lauralyn McIntyre MD
Associate Professor in the Department of Medicine, University of Ottawa
Senior Scientist with the Clinical Epidemiology Department of the Ottawa Hospital Research Institute
2019-12-13 08:15:00 - 2019-12-13 08:35:00
Stem Cells and Genomics for Precision Cardiovascular Medicine
- Joseph C. Wu MD, PhD
Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD
Professor of Medicine & Radiology Stanford University School of Medicine
2019-12-13 08:35:00 - 2019-12-13 08:55:00
Regenerative Medicine Advances in Healthcare
- Anthony Atala MD
Professor of Surgery
Chair, Department of Urology
Director, Wake Forest Institute for Regenerative Medicine at Wake Forest University
2019-12-13 08:55:00 - 2019-12-13 09:15:00
Cellular Therapies in ARDS – Pre-clinial to Clinical Trials
- Michael Matthay MD
Professor of Pulmonary Critical Care Medicine
Associate Director of ICU
University of California San Francisco
2019-12-13 09:15:00 - 2019-12-13 09:35:00
Inflammatory Lung Environment Effects on MSC Behaviors
- Daniel Weiss MD, PhD
Professor of Medicine
University of Vermont
ISCT Chief Scientific Officer
2019-12-13 09:35:00 - 2019-12-13 09:55:00
Multipotent Adult Progenitor Cells in ARDS
- Robert Mays PhD
Vice President, Regenerative Medicine
Head of Neurosciences, Athersys, Inc.
2019-12-13 09:55:00 - 2019-12-13 10:10:00
Question & Answer Panel | Session 1
2019-12-13 10:10:00 - 2019-12-13 10:30:00
Coffee Break – Aragon Ballroom Foyer
Visit Exhibits
Session 2 | Cellular Therapies in Neurotrauma and Organ Regeneration
Moderator(s)- Deborah Stein MD
Professor and Chief of Surgery
Zuckerberg San Francisco General,
Vice Chair of Trauma and Critical Care Surgery
UCSF Department of Surgery - Hasan Alam MD
Norman W. Thompson Professor of Surgery
Section Head of General Surgery
University of Michigan
2019-12-13 10:30:00 - 2019-12-13 10:50:00
Adult and Pediatric Clinical Trials of HSCs and MAPCs in Traumatic Brain Injury (TBI)
- Charles Cox MD
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth
2019-12-13 10:50:00 - 2019-12-13 11:10:00
Human Neural Stem Cell Grafts for Repair of Spinal Cord Injury
- Ephron Rosenzweig PhD
Assistant Professor of Neurosciences
Center for Neural Repair
University of California San Diego
2019-12-13 11:10:00 - 2019-12-13 11:30:00
Human Clinical Trial of Neural Progenitor Cells in SCI
- Joel Martin MD
Senior Resident in Neurosurgery
University of California San Diego
2019-12-13 11:30:00 - 2019-12-13 11:45:00
Question & Answer Panel | Session 2
2019-12-13 11:45:00 - 2019-12-13 12:00:00
Mission of BARDA in Novel Blood Product Development
- Erika Davies PhD
Health Scientist
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures (DBRN)
Biomedical Advanced Research and Development Authority (BARDA)
2019-12-13 12:00:00 - 2019-12-13 12:25:00
Featured Presentation | FDA’s Role in Facilitating the Development of Cellular Therapies
- Peter Marks MD, PhD
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
2019-12-13 12:30:00 - 2019-12-13 13:30:00
Lunch – Aragon Lawn
Visit Exhibits
Session 3 | Cellular Therapies for Wound Healing, Bone Healing and Burns
Moderator(s)- Jan Nolta PhD
Director, Stem Cell Program and Institute for Regenerative Cures
University of California Davis Health
Scientific Director, UC Davis GMP Facility
Editor-in-Chief, Stem Cells - Samuel P. Carmichael II MD
Acute Care Surgery Fellow
Wake Forest Baptist Medical Center
2019-12-13 13:30:00 - 2019-12-13 13:50:00
Innate Immunity in Injury
- Clifford Lowell MD, PhD
Professor and Distinguished Chairman Department of Laboratory Medicine, UCSF
2019-12-13 13:50:00 - 2019-12-13 14:10:00
Stem Cells in Wound Healing & Tissue Repair
- Jan Nolta PhD
Director, Stem Cell Program and Institute for Regenerative Cures
University of California Davis Health
Scientific Director, UC Davis GMP Facility
Editor-in-Chief, Stem Cells
2019-12-13 14:10:00 - 2019-12-13 14:30:00
Pluripotent Stem Cells for Skeletal Regeneration and the Hematopoietic Niche
- Joy Wu MD
Assistant Professor of Medicine
Co Director Translational Investigator Program
Stanford University
2019-12-13 14:30:00 - 2019-12-13 14:50:00
French Military Clinical Experience with MSCs in Thermal and Radiation Burn Injury
- Christophe Martinaud MD
Professor of Transfusion Medicine and Cell Therapy
French Military Blood Institute Clamart
2019-12-13 14:50:00 - 2019-12-13 15:10:00
Question & Answer Panel | Session 3
2019-12-13 15:10:00 - 2019-12-13 15:25:00
Break – Aragon Ballroom Foyer
Visit Exhibits
Session 4 | New Technologies, Regulatory Issues and Challenges in the Field
Moderator(s)- Michael Matthay MD
Professor of Pulmonary Critical Care Medicine
Associate Director of ICU
University of California San Francisco
2019-12-13 15:25:00 - 2019-12-13 15:45:00
Development of a Donor-Independent Platelet-Like Cellular Therapy
- Tom Schulz PhD
VP of Manufacturing Sciences, Platelet BioGenesis
2019-12-13 15:45:00 - 2019-12-13 16:05:00
The Cell Therapy Translational Pipeline from Bench to Bedside with New Emerging Technologies: Perspectives on CAR-T cells and IPSC derived Cells and Tissue
- Jürgen Schmitz PhD
Chief Scientific Officer
Miltenyi Biotec
2019-12-13 16:05:00 - 2019-12-13 16:25:00
Ex Vivo Mesenchymal Stromal Cell Therapy for the Treatment of Systemic Inflammatory Disease
- Biju Parekkadan PhD
Associate Professor, Biomedical Engineering, Rutgers University
Division Leader, Center for Surgery, Innovation, and Bioengineering, Harvard Medical School and Massachusetts General Hospital
Affiliated Faculty, Harvard Stem Cell Institute and the Broad Institute for Genetics
Co-Founder, Director, and Office of Chief Scientific Officer, Sentien Biotechnologies, Inc.
2019-12-13 16:25:00 - 2019-12-13 16:30:00
Concluding Remarks
- Martin Schreiber MD
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU) - Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
2019-12-13 16:30:00 - 2019-12-13 17:30:00
Closing Cocktail Reception